vs
Side-by-side financial comparison of Brightstar Lottery PLC (BRSL) and DaVita (DVA). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $2.5B, roughly 1.4× Brightstar Lottery PLC). DaVita runs the higher net margin — 6.5% vs 5.9%, a 0.6% gap on every dollar of revenue.
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
BRSL vs DVA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $3.6B |
| Net Profit | $147.0M | $234.2M |
| Gross Margin | — | — |
| Operating Margin | 11.9% | 15.5% |
| Net Margin | 5.9% | 6.5% |
| Revenue YoY | — | 12.3% |
| Net Profit YoY | — | 43.8% |
| EPS (diluted) | $0.74 | $3.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.6B | ||
| Q4 25 | $2.5B | $3.6B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.4B | ||
| Q1 25 | — | $3.2B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.3B | ||
| Q2 24 | — | $3.2B |
| Q1 26 | — | $234.2M | ||
| Q4 25 | $147.0M | $234.2M | ||
| Q3 25 | — | $150.3M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $162.9M | ||
| Q4 24 | — | $259.3M | ||
| Q3 24 | — | $214.7M | ||
| Q2 24 | — | $222.7M |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 11.9% | 15.5% | ||
| Q3 25 | — | 14.8% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 16.4% | ||
| Q2 24 | — | 15.9% |
| Q1 26 | — | 6.5% | ||
| Q4 25 | 5.9% | 6.5% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 5.9% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 7.0% |
| Q1 26 | — | $3.22 | ||
| Q4 25 | $0.74 | $3.22 | ||
| Q3 25 | — | $2.04 | ||
| Q2 25 | — | $2.58 | ||
| Q1 25 | — | $2.00 | ||
| Q4 24 | — | $3.08 | ||
| Q3 24 | — | $2.50 | ||
| Q2 24 | — | $2.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $700.7M |
| Total DebtLower is stronger | $4.1B | $10.2B |
| Stockholders' EquityBook value | $875.0M | $-651.1M |
| Total Assets | $9.2B | $17.5B |
| Debt / EquityLower = less leverage | 4.64× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $700.7M | ||
| Q4 25 | $1.4B | $700.7M | ||
| Q3 25 | — | $736.5M | ||
| Q2 25 | — | $739.4M | ||
| Q1 25 | — | $511.9M | ||
| Q4 24 | — | $846.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $437.2M |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $4.1B | $10.2B | ||
| Q3 25 | — | $10.2B | ||
| Q2 25 | — | $10.1B | ||
| Q1 25 | — | $9.6B | ||
| Q4 24 | — | $9.2B | ||
| Q3 24 | — | $9.3B | ||
| Q2 24 | — | $8.5B |
| Q1 26 | — | $-651.1M | ||
| Q4 25 | $875.0M | $-651.1M | ||
| Q3 25 | — | $-571.9M | ||
| Q2 25 | — | $-369.6M | ||
| Q1 25 | — | $-267.1M | ||
| Q4 24 | — | $121.1M | ||
| Q3 24 | — | $386.7M | ||
| Q2 24 | — | $632.9M |
| Q1 26 | — | $17.5B | ||
| Q4 25 | $9.2B | $17.5B | ||
| Q3 25 | — | $17.6B | ||
| Q2 25 | — | $17.5B | ||
| Q1 25 | — | $17.1B | ||
| Q4 24 | — | $17.3B | ||
| Q3 24 | — | $17.5B | ||
| Q2 24 | — | $17.0B |
| Q1 26 | — | — | ||
| Q4 25 | 4.64× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 75.76× | ||
| Q3 24 | — | 23.95× | ||
| Q2 24 | — | 13.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-99.0M | — |
| Free Cash FlowOCF − Capex | $-415.0M | — |
| FCF MarginFCF / Revenue | -16.5% | — |
| Capex IntensityCapex / Revenue | 12.6% | — |
| Cash ConversionOCF / Net Profit | -0.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-99.0M | $540.7M | ||
| Q3 25 | — | $841.5M | ||
| Q2 25 | — | $324.2M | ||
| Q1 25 | — | $180.0M | ||
| Q4 24 | — | $547.6M | ||
| Q3 24 | — | $810.4M | ||
| Q2 24 | — | $798.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-415.0M | $395.3M | ||
| Q3 25 | — | $675.4M | ||
| Q2 25 | — | $203.1M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | $377.0M | ||
| Q3 24 | — | $671.4M | ||
| Q2 24 | — | $674.1M |
| Q1 26 | — | — | ||
| Q4 25 | -16.5% | 10.9% | ||
| Q3 25 | — | 19.7% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 20.6% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 12.6% | 4.0% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | — | 3.9% |
| Q1 26 | — | — | ||
| Q4 25 | -0.67× | 2.31× | ||
| Q3 25 | — | 5.60× | ||
| Q2 25 | — | 1.63× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 2.11× | ||
| Q3 24 | — | 3.77× | ||
| Q2 24 | — | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
